Slaton v. Bristol-Meyers Squibb Company et al

Filing 4

CONDITIONAL TRANSFER ORDER - Certified Copy. (CTO-9) MDL No. 2809. (pts) [Transferred from gasd on 4/18/2018.]

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: ONGLYZA (SAXAGLIPTIN) AND
KOMBIGLYZE XR (SAXAGLIPTIN AND
METFORMIN) PRODUCTS LIABILITY
LITIGATION

MDL No. 2809

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO −9)

On February 2, 2018, the Panel transferred 39 civil action(s) to the United States District Court for
the Eastern District of Kentucky for coordinated or consolidated pretrial proceedings pursuant to 28
U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2018). Since that time, 52 additional action(s) have been
transferred to the Eastern District of Kentucky. With the consent of that court, all such actions have
been assigned to the Honorable Karen K Caldwell.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Eastern District of Kentucky and assigned to
Judge Caldwell.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Eastern District of Kentucky for the reasons stated in the order of February 2, 2018, and, with the
consent of that court, assigned to the Honorable Karen K Caldwell.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Eastern District of Kentucky. The transmittal of this order to said Clerk shall
be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7−day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

Apr 18, 2018

Jeffery N. Lüthi
Clerk of the Panel

FILED AND CERTIFIED
ROBERT R. CARR, CLERK
U.S. DISTRICT COURT
EASTERN DISTRICT OF KENTUCKY
Date:

4/18/2018

By:

C. Dearborn
Deputy Clerk

IN RE: ONGLYZA (SAXAGLIPTIN) AND
KOMBIGLYZE XR (SAXAGLIPTIN AND
METFORMIN) PRODUCTS LIABILITY
LITIGATION

MDL No. 2809

SCHEDULE CTO−9 − TAG−ALONG ACTIONS

DIST

DIV.

C.A.NO.

CASE CAPTION

4

18−00172

Peoples v. Bristol−Myers Squibb Company et al

18−00231

Booth v. Bristol Myers Squibb Company et al

ARIZONA
AZ

ARKANSAS EASTERN
ARE

4

CALIFORNIA EASTERN
CAE

2

18−00680

Stewart v. Bristol−Myers Squibb Company et al

18−01292

Walz v. Bristol−Myers Squibb Company et al

18−00060

Slaton v. Bristol−Meyers Squibb Company et al

18−50110

Mills v. Bristol−Myers Squibb Company et al

18−00632

Gintz v. Bristol−Myers Squibb Company et al

WOODRUFF v. BRISTOL−MYERS SQUIBB
COMPANY et al
HARDIN v. BRISTOL−MYERS SQUIBB COMPANY
et al

GEORGIA NORTHERN
GAN

1

GEORGIA SOUTHERN
GAS

1

ILLINOIS NORTHERN
ILN

3

ILLINOIS SOUTHERN
ILS

3

INDIANA SOUTHERN
INS

1

18−00984

INS

4

18−00055

KENTUCKY WESTERN

KYW

5

18−00049

Kee v. Bristol−Myers Squibb Company et al

MISSISSIPPI NORTHERN
MSN

1

18−00061

Loggan v. Bristol−Myers Squibb Company et al

MISSISSIPPI SOUTHERN
MSS
MSS
MSS

3
3
3

18−00201
18−00202
18−00214

Maurras v. Bristol−Myers Squibb Company et al
Harrell v. Bristol Myers Squibb Company et al
Garrette v. Bristol−Myers Squibb Company et al

Wood v. Bristol Myers Squibb Company et al
Payne v. Bristol Myers Squibb Company et al
Ganzalez−McAllister v. Bristol Myers Squibb Company
et al

MISSOURI WESTERN
MOW
MOW

4
4

18−00258
18−00259

MOW

4

18−00260

NEW YORK SOUTHERN
NYS
NYS
NYS
NYS
NYS
NYS
NYS
NYS

1
1
1
1
1
1
1
1

18−02860
18−02862
18−02863
18−02866
18−02914
18−02915
18−02917
18−02955

Orschel v. Astrazeneca LP et al
Carter v. Bristol−Myers Squibb Company et al
Forgione v. Bristol−Myers Squibb Company et al
Rouse v. Bristol−Myers Squibb Company et al
Havice v. Bristol−Myers Squibb Company et al
Waterman v. Bristol−Myers Squibb Company et al
Gooch v. Bristol−Myers Squibb Company et al
Trapp et al v. Bristol−Myers Squibb Company et al

NORTH CAROLINA EASTERN
NCE

7

18−00052

Royal v. Bristol−Myers Squibb Company et al

NORTH CAROLINA MIDDLE
NCM

1

18−00265

KEY v. BRISTOL−MYERS SQUIBB COMPANY, et
al

18−00715

Clark et al v. Bristol−Myers Squibb Company et al

OHIO NORTHERN
OHN

3

OKLAHOMA WESTERN
OKW

5

18−00283

Brittain v. Bristol−Myers Squibb Company et al

18−00824
18−00825

Erwin v. Bristol−Myers Squibb Company et al
Fouse v. Bristol−Myers Squibb Company et al

TEXAS NORTHERN
TXN
TXN

3
3

TXN
TXN
TXN
TXN

3
3
3
7

18−00826
18−00827
18−00828
18−00045

Crear v. Bristol−Myers Squibb Company et al
Sheppard v. Bristol−Myers Squibb Company et al
Bivins v. Bristol−Myers Squibb Company et al
Hasan v. Bristol−Myers Squibb Company et al

18−00092
18−00969
18−00971

Gordon v. Bristol−Myers Squibb Company et al
Jones v. Bristol−Myers Squibb Company et al
Sparkman v. Bristol−Myers Squibb Company et al

TEXAS SOUTHERN
TXS
TXS
TXS

2
4
4

WASHINGTON EASTERN
WAE

1

18−03049

Smith v. Bristol−Myers Squibb Company et al

18−00511

Jarman v. Bristol−Myers Squibb Company et al

WISCONSIN EASTERN
WIE

2